eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2019
vol. 36
 
Share:
Share:
more
 
 
abstract:
Special paper

Asthma and exercise-induced respiratory disorders in athletes. The position paper of the Polish Society of Allergology and Polish Society of Sports Medicine

Radoslaw Gawlik, Marcin Kurowski, Marek Kowalski, Ziemowit Ziętkowski, Andrzej Pokrywka, Hubert Krysztofiak, Jarosław Krzywański, Andrzej Bugajski, Zbigniew Bartuzi

Adv Dermatol Allergol 2019; XXXVI (1): 1-10
Online publish date: 2019/02/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Exercise-induced respiratory symptoms describe acute airway narrowing that occurs as a result of exercise. It includes exercise-induced bronchoconstriction (EIB) and exercise-induced asthma (EIA) issues. To provide clinicians with practical guidelines, a multidisciplinary panel of stakeholders was convened to review the pathogenesis of EIB/EIA and to develop evidence-based guidelines for the diagnosis and treatment. Recommendations for the diagnosis and treatment of EIB were developed. High-intensity exercise in polluted environment (cold air, humidity, contamination, allergens) may increase the risk of EIB and asthma symptoms in athletes. Diagnostic procedures should include history taking, physical examination, atopy assessment and functional tests of the respiratory system. A strong recommendation was made for regular use of inhaled glucocorticosteroids and avoidance of short-acting 2-agonists as the only treatment. The treatment of asthma in athletes should always take into account current anti-doping regulations. This position paper reflects the currently available evidence.
keywords:

exercise-induced bronchoconstriction, diagnosis, treatment

references:
Langdeau J, Turcotte H, Bowie D, et al. Airway hyperresponsiveness in elite athletes. Am J Respir Crit Care Med 2000; 161: 1479-84.
Sue-Chu M. Winter sports athletes: long-term effects of cold air exposure. Br J Sports Med 2012; 46: 397-401.
Voy R. The U.S. Olympic committee experience with exercise-induced bronchospasm, 1984. Med Sci Sports Exerc 1986; 18: 328-30.
Weiler J, Layton T, Hunt M. Asthma in united states olympic athletes who participated in the 1996 summer games. J Allergy Clin Immunol 1998; 102: 722-6.
Weiler J, Ryan III E. Asthma in united states olympic athletes who participated in the 1998 olympic winter games. J Allergy Clin Immunol 2000; 106: 267-71.
Bonini M, Gramiccioni C, Fioretti D, et al. Asthma, allergy and the olympics: a 12-year survey in elite athletes. Curr Opin Allergy Clin Immunol 2015; 15: 184-92.
Carlsen K, Anderson S, Bjermer L, et al. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: Part i of the report from the joint task force of the
European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 2008; 63: 387-403.
Carlsen KH, Anderson S, Bjermer L, et al. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part ii of the report from the joint task force of e European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 2008; 63: 492-505.
Carlsen KH, Kowalski M. Asthma, allergy, the athlete and the olympics. Allergy 2008; 63: 383-6. Kurowski M, Jurczyk J, Krysztofiak H, Kowalski ML. Exercise-induced respiratory symptoms and allergy in elite athletes: allergy and asthma in polish olympic athletes (A2POLO) project within GA2LEN initiative. Clin Respir J 2016; 10: 231-8.
Burns J, Mason C, Mueller N, et al. Asthma prevalence in olympic summer athletes and the general population: an analysis of three european countries. Resp Med 2015; 109: 813-20.
Bernard A, Carbonnelle S, de Burbure C, et al. Chlorinated pool attendance, atopy, and the risk of asthma during childhood. Environ Health Perspect 2006; 114: 1567-73.
Bernard A, Carbonnelle S, Dumont X, Nickmilder M. Infant swimming practice, pulmonary epiuthelium integrity, and the risk of allergic and respiratory diseases later in childhood. Pediatrics 2007; 119: 1095-103.
Bernard A, Carbonnelle S, Michel O, et al. Lung hyperpermeability and asthma prevalence in schoolchildren: unexpected associations with the attendance at indoor chlorinated swimming pools. Occup Environ Med 2003; 60: 385-94.
Drobnic F, Freixa A, Casan P, et al. Assessment of chlorine exposure in swimmers during training. Med Sci Sports Exerc 1996; 28: 271-4.
Kennedy MD, Davidson WJ, Wong LE, et al. Airway inflammation, cough and athlete quality of life in elite female cross-country skiers: a longitudinal study. Scand J Med Sci Sports 2016; 26: 835-42.
Larsson K, Ohlsén P, Larsson L, et al. High prevalence of asthma in cross country skiers. Br Med J 1993; 307: 1326-9.
Porter EB. Common injuries and medical problems in singles figure skaters. Curr Sports Med Rep 2013; 12: 318-20.
Provost-Craig MA, Arbour KS, Sestili DC, et al. The incidence of exercise-induced bronchospasm in competitive figure skaters. J Asthma 1996; 33: 67-71.
Stensrud T, Mykland K, Gabrielsen K, Carlsen K. Bronchial hyperresponsiveness in skiers: field test versus methacholine provocation? Med Sci Sports Exerc 2007; 39: 1681-6.
Vergès S, Flore P, Blanchi MP, Wuyam B. A 10-year follow-up study of pulmonary function in symptomatic elite cross-country skiers – athletes and bronchial dysfunctions. Scand J Med Sci Sports 2004; 14: 381-7.
Couto M, Kurowski M, Moreira A, et al. Mechanisms of exercise-induced bronchoconstriction in athletes: current perspectives and future challenges. Allergy 2018; 73: 8-16.
Carbonnelle S, Francaux M, Doyle I, et al. Changes in serum pneumoproteins caused by short-term exposures to nitrogen trichloride in indoor chlorinated swimming-pools. Biomarkers 2002; 7: 464-78.
Kurowski M, Jurczyk J, Jarzębska M, et al. Association of serum clara cell protein cc16 with respiratory infections and immune response to respiratory pathogens in elite athletes. Respir Res 2014; 15: 45.
Romberg K, Bjermer L, Tufvesson E. Exercise but not mannitol provocation increases urinary clara cell protein (cc16) in elite swimmers. Resp Med 2011; 105: 31-6.
Seys SF, Feyen L, Keirsbilck S, et al. An outbreak of swimming-pool related respiratory symptoms: an elusive source of trichloramine in a municipal indoor swimming pool. Int J Hyg Environ Health 2015; 218: 386-91.
Seys SF, Hox V, Van Gerven L, et al. Damage-associated molecular pattern and innate cytokine release in the airways of competitive swimmers. Allergy 2015; 70: 187-94.
Larsson L, Hemminqsson P, Boëthius G. Self-reported obstructive airway symptoms are common in young cross-country skiers. Scand J Med Sci Sports 1994; 4: 124-7.
Couto M, Silva D, Santos P, et al. Exploratory study comparing dysautonomia between asthmatic and non-asthmatic elite swimmers. Rev Port Pneumol 2015; 21: 22-9.
Stang J, Stensrud T, Mowinckel P, Carlsen K. Parasympathetic activity and bronchial hyperresponsiveness in athletes. Med Sci Sports Exerc 2016; 48: 2100-7.
Moreira A, Delgado L, Carlsen K. Exercise-induced asthma: why is it so frequent in olympic athletes? Expert Rev Respir Med 2011; 5: 1-3.
Bonini M, Palange P. Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment. Asthma Res Prac 2015; 1: 2.
Schwartz L, Delgado L, Craig T, et al. Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a practall consensus report (what the general practitioner should know about sports and allergy). Allergy 2008; 63: 953-61.
Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26: 153-61.
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
Cockcroft D. Direct challenge tests. Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138: 18S-24S.
Rundell K, Slee J. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol 2008; 122: 238-46.
Weiler J, Bonini S, Coifman R, et al. American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol 2007; 119: 1349-58.
Crapo R, Casaburi R, Coates A, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Resp Crit Care Med 2000; 161: 309-29.
Carlsen K, Engh G, Mørk M. Exercise-induced bronchoconstriction depends on exercise load. Respir Med 2000; 94: 750-5.
Taylor D. Nitric oxide as a clinical guide for asthma management. J Allergy Clin Immunol 2006; 117: 259-62.
Gina Report, Global Strategy for Asthma Management and Prevention. Updated 2011.
http://www.Ginasthma.Org/uploads/users/files/gina_report2011_may4.pdf [accessed 23 June 2012].
Couto M, Stang J, Horta L, et al. Two distinct phenotypes of asthma in elite athletes identified by latent class analysis. J Asthma 2015; 52: 897-90.
Fitch K. An overview of asthma and airway hyper-responsiveness in olympic athletes. Br J Sports Med 2012; 46: 413-6.
Hoshino Y, Koya T, Kagamu H, et al. Effect of inhaled corticosteroids on bronchial asthma in Japanese athletes. Allergol Int 2015; 64: 145-9.
Duong M, Amin R, Baatjes A, et al. The effect of montelukast, budesonide alone, and in combination on exercise induced bronchoconstriction. J Allergy Clin Immunol 2012; 130: 535-9.
Rundell K, Spiering B, Baumann J, Evans T. Bronchoconstriction provoked by exercise in a high-particulatematter environment is attenuated by montelukast. Inhal Toxicol 2005; 17: 99-105.
Villaran C, O’Neill S, Helbling A, van Noord J. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/salmeterol exercise study group. J Allergy Clin Immunol 1999; 104: 547-53.
Edelman J, Turpin J, Bronsky E, et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise study group. Ann Intern Med 2000; 132: 97-104.
Levenson M. Long-acting beta-agonists and adverse asthma events meta-analysis. FDA Briefing Material November 12, 2008.
Hancox R, Subbarao P, Kamada D, et al Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Resp Crit Care Med 2002; 165: 1068-70.
Muraro A, Roberts G. EAACI Allergen Immunotherapy Guidelines. EAACI, Zurych 2017.
Zielen S, Kardos P, Madonini E. Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial. J Allergy Clin Immunol 2010; 126: 942-9.
Spooner C, Spooner G, Rowe B. Mast-cell stabilizing agents to prevent exercise induced bronchoconstriction. Cochrane Database Syst Rev 2003; 4: CD002307.
Gałązka-Franta A, Jura-Szołtys E, Smółka W, Gawlik R. Upper respiratory tract diseases in athletes in different sports disciplines. J Hum Kinet 2016; 53: 99-106.
Gleeson M, Pyne D. Respiratory inflammation and infections in high-performance athletes. Immunol Cell Biol 2016; 94: 124-31.
Price O, Hull J, Howatson G, et al. Vitamin D and omega-3 polyunsaturated fatty acid supplementation in athletes with exercise-induced bronchoconstriction: a pilot study. Expert Rev Respir Med 2015; 9: 369-78.
Price O, Hull J. Asthma in elite athletes: Who cares? Clin Pulm Med 2014; 21: 68-75.
Beuther D, Martin R. Efficacy of a heat exchanger mask in cold exercise-induced asthma. Chest 2006; 129: 1188-93.
Turowski D, Kończak D, Michalak D, Pokrywka A. Zasady postępowania w astmie i nadreaktywności oskrzeli u sportowców wyczynowych. Alergia Astma Immunol 2014; 19: 135-43.
The World-Anti Doping Code, International Standard, Prohibited List, january 2018. World Anti-Doping Agency.
Kaliszewski P, Kończak D, Chołbiński P, et al. Budesonide treatment of professional athletes and anti-doping testing – case studies. Acta Pol Pharm 2016; 73: 229-37.
Görgens C, Guddat S, Thomas A, et al. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry. J Pharm Biomed Anal 2016; 131: 482-96.
Bai G, Yang Y, Shi Q, et al. Identification of higenamine in radix aconiti lateralis preparata as a beta2-adrenergic receptor agonist. Acta Pharmacol Sin 2008; 29: 1187-94.
Jeter J, DeZee K, Kennedy L. A case of paraspinal muscle rhabdomyolysis in a 22-year-old male after ingesting a supplement containing higenamine. Mil Med 2015; 180: e847-9.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe